News & Media / Press Releases

WBB Securities Asset Management Receives Hedgeweek Award For Life Sciences Investing

September 22, 2017

WBB Securities, LLC is pleased to announce that the WBB Asset Management Long/Short Life Science Strategy (LSLSS) was the recipient of Hedgeweek USA’s 2017 Award for Best Event Driven Strategy last night in New York City.

Continue Reading

WBB Securities Acts as Co-Manager in $17 Million Follow-on Financing for T2 Biosystems

September 21, 2017

WBB Securities acted as co-manager to a transaction for T2 Biosystems, Inc., a manufacturer of next generation, rapid diagnostic equipment.

Continue Reading

WBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.

May 31, 2017

WBB Securities acted as co-manager to a transaction for Corium International, Inc., a commercial stage developer of transdermal healthcare products.

Continue Reading

WBB Securities Acts as Financial Advisor to T2 Biosystems for $50 Million Credit Facility

January 5, 2017

WBB Securities acted as financial advisor to T2 Biosystems, Inc., a manufacturer of next generation diagnostic equipment, for a credit facility up to $50 million.

Continue Reading

WBB Securities Acts as Co-Manager for $300 Million Public Offering for Sarepta Therapeutics

September 29, 2016

WBB Securities acted as co-manager to a transaction for Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics.

Continue Reading

John Nolan Joins WBB to Head Asset Management Team

September 2, 2016

WBB Securities, a leading investment management, investment banking, and equity research firm, announced today that John Nolan has joined the firm as Managing Director of WBB Asset Management[1] where he will also serve as a Portfolio Manager of a concentrated long/short portfolio that focuses on the biotechnology, specialty pharmaceutical and medical device sectors.

Continue Reading

WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference

September 1, 2016

WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.

Continue Reading

WBB Securities Sponsors BioCentury’s 2016 Future Leaders Conference

March 1, 2016

WBB Securities is a sponsor of this year’s Future Leader’s conference.

Continue Reading

WBB Securities Acts as Co-manager for $100 Million in Public Offering for Cempra Pharmaceuticals

January 12, 2016

WBB Securities acted as co-manager to a transaction for Cempra Pharmaceuticals, a clinical-stage biopharmaceutical company focused on discovering and developing novel antibiotics.

Continue Reading

WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference

September 1, 2015

WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.

Continue Reading